Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2013

01.05.2013 | Gastrointestinal Oncology

Comparison of Billroth I and Roux-en-Y Reconstruction after Distal Gastrectomy for Gastric Cancer: One-year Postoperative Effects Assessed by a Multi-institutional RCT

verfasst von: Motohiro Hirao, MD, PhD, Shuji Takiguchi, MD, PhD, Hiroshi Imamura, MD, PhD, Kazuyoshi Yamamoto, MD, PhD, Yukinori Kurokawa, MD, PhD, Junya Fujita, MD, PhD, Kenji Kobayashi, MD, PhD, Yutaka Kimura, MD, PhD, Masaki Mori, MD, PhD, Yuichiro Doki, MD, PhD, Osaka University Clinical Research Group for Gastroenterological Study

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This randomized, controlled trial evaluated the clinical efficacy of Billroth I (BI) and Roux-en-Y (RY) reconstruction at 1 year after distal gastrectomy for gastric cancer.

Methods

The primary end point was the amount of body weight lost at 1 postoperative year, and secondary end points included other items related to nutritional status such as serum albumin and lymphocyte count, as well as endoscopic examination findings of the remnant stomach and esophagus. Of the 332 patients enrolled, 163 were assigned to the BI group and 169 were randomized to the RY group.

Results

The loss in body weight 1 year after surgery did not differ significantly between the BI and RY groups (9.1 % and 9.7 %, respectively, p = 0.39). There were no significant differences in other aspects of nutritional status between the 2 groups. Endoscopic examination 1 year after gastrectomy showed reflux esophagitis in 26 patients (17 %) in the BI group versus 10 patients (6 %) in the RY group (p = 0.0037), while remnant gastritis was observed in 71 patients (46 %) in the BI group versus 44 patients (28 %) in the RY group (p = 0.0013); differences were significant for both conditions. Multivariable analysis showed that the only reconstruction was the independently associated factor with the incidence of reflux esophagitis.

Conclusions

RY reconstruction was not superior to BI in terms of body weight change or other aspects of nutritional status at 1 year after surgery, although RY more effectively prevented reflux esophagitis and remnant gastritis after distal gastrectomy.
Literatur
1.
Zurück zum Zitat Yoshino K. History of gastric cancer surgery. J Jpn Surg Soc. 2000;101:855–60. Yoshino K. History of gastric cancer surgery. J Jpn Surg Soc. 2000;101:855–60.
2.
Zurück zum Zitat Taylor PR, Mason RC, Filipe MI, et al. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labeling index. Gut. 1991;32:1447–54.PubMedCrossRef Taylor PR, Mason RC, Filipe MI, et al. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labeling index. Gut. 1991;32:1447–54.PubMedCrossRef
3.
Zurück zum Zitat Fein M, Peters JH, Chandrasoma P, et al. Duodenoesophageal refluxinduces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg. 1998;2:260–8.PubMedCrossRef Fein M, Peters JH, Chandrasoma P, et al. Duodenoesophageal refluxinduces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg. 1998;2:260–8.PubMedCrossRef
4.
Zurück zum Zitat Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis. 1997;18:2265–70.PubMedCrossRef Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis. 1997;18:2265–70.PubMedCrossRef
5.
Zurück zum Zitat Fukuhara K, Osugi H, Takeda N, et al. Reconstructive procedure after distal gastrectomy for gastric cancer that best prevents duodenenoesophageal reflux. World J Surg. 2002;26:1452–7.PubMedCrossRef Fukuhara K, Osugi H, Takeda N, et al. Reconstructive procedure after distal gastrectomy for gastric cancer that best prevents duodenenoesophageal reflux. World J Surg. 2002;26:1452–7.PubMedCrossRef
6.
Zurück zum Zitat Mathias JR, Fernandez A, Sninsky CA, et al. Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb. Gastroenterology. 1985;88:101–7.PubMed Mathias JR, Fernandez A, Sninsky CA, et al. Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb. Gastroenterology. 1985;88:101–7.PubMed
7.
Zurück zum Zitat Kojima K, Yamada H, Inokuchi M, et al. A comparison of Roux-en-Y and Billroth-I reconstruction after laparoscopy-assisted distal gastrectomy. Ann Surg. 2008;247:962–7.PubMedCrossRef Kojima K, Yamada H, Inokuchi M, et al. A comparison of Roux-en-Y and Billroth-I reconstruction after laparoscopy-assisted distal gastrectomy. Ann Surg. 2008;247:962–7.PubMedCrossRef
8.
Zurück zum Zitat Ishikawa M, Kitayama J, Kaizaki S, et al. Prospective randomized trial comparing Billroth-I and Roux-en-Y procedures after distal gastrectomy for gastric cancer. World J Surg. 2005;29:1415–20.PubMedCrossRef Ishikawa M, Kitayama J, Kaizaki S, et al. Prospective randomized trial comparing Billroth-I and Roux-en-Y procedures after distal gastrectomy for gastric cancer. World J Surg. 2005;29:1415–20.PubMedCrossRef
9.
Zurück zum Zitat Montesani C, D’Amato A, Santella S, et al. Billroth-I versus Billroth-II versus Roux-en-Y after subtotal gastrectomy. Prospective randomized study. Hepatogastroenterology. 2002;49:1469–73.PubMed Montesani C, D’Amato A, Santella S, et al. Billroth-I versus Billroth-II versus Roux-en-Y after subtotal gastrectomy. Prospective randomized study. Hepatogastroenterology. 2002;49:1469–73.PubMed
10.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13th edition. Tokyo: Kanehara; 1999. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13th edition. Tokyo: Kanehara; 1999.
11.
Zurück zum Zitat Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRef Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRef
12.
Zurück zum Zitat Demas GE, Drazen DL, Nelson RJ, et al. Reductions in total body fat decrease humoral immunity. Proc R Soc B Biol Sci. 2003;270:905–11.CrossRef Demas GE, Drazen DL, Nelson RJ, et al. Reductions in total body fat decrease humoral immunity. Proc R Soc B Biol Sci. 2003;270:905–11.CrossRef
13.
Zurück zum Zitat Marinho LA, Rettori O, Vieira-Matos AN, et al. Body weight loss as an indicator of breast cancer recurrence. Acta Oncol. 2001;40:832–7.PubMedCrossRef Marinho LA, Rettori O, Vieira-Matos AN, et al. Body weight loss as an indicator of breast cancer recurrence. Acta Oncol. 2001;40:832–7.PubMedCrossRef
14.
Zurück zum Zitat Tsugane S, Sasaki S, Tsubono Y. Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC study cohort I. Int J Obes Relat Metab Disord. 2002;6:529–37.CrossRef Tsugane S, Sasaki S, Tsubono Y. Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC study cohort I. Int J Obes Relat Metab Disord. 2002;6:529–37.CrossRef
15.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nippon Geka Gakkai Zashi. 1984;85:1001–5. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nippon Geka Gakkai Zashi. 1984;85:1001–5.
16.
Zurück zum Zitat Imamura H, Takiguchi S, Yamamoto K, et al. Morbidity and mortality results from a prospective randomized controlled trial comparing billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer. World J Surg. 2012;36:632–7.PubMedCrossRef Imamura H, Takiguchi S, Yamamoto K, et al. Morbidity and mortality results from a prospective randomized controlled trial comparing billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer. World J Surg. 2012;36:632–7.PubMedCrossRef
17.
Zurück zum Zitat Takiguchi S, Yamamoto K, Hirao M, et al. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distalgastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer. 2012;15:198–205.PubMedCrossRef Takiguchi S, Yamamoto K, Hirao M, et al. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distalgastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer. 2012;15:198–205.PubMedCrossRef
18.
Zurück zum Zitat Fujita J, Imamura H, Takiguchi K, et al. Randomized controlled trial comparing Billroth-I and Roux-en-Y reconstruction in distal gastrectomy for gastric cancer. ASCO GI. In press. Fujita J, Imamura H, Takiguchi K, et al. Randomized controlled trial comparing Billroth-I and Roux-en-Y reconstruction in distal gastrectomy for gastric cancer. ASCO GI. In press.
19.
Zurück zum Zitat Shinoto K, Ochiai T, Suzuki T, et al. Effectiveness of Roux-en-Y reconstruction after distal gastrectomy based on an assessment of biliary kinetics. Surg Today. 2003;33:169–77.PubMedCrossRef Shinoto K, Ochiai T, Suzuki T, et al. Effectiveness of Roux-en-Y reconstruction after distal gastrectomy based on an assessment of biliary kinetics. Surg Today. 2003;33:169–77.PubMedCrossRef
20.
Zurück zum Zitat Fukuhara K, Osugi H, Takeda N, et al. Quantitative determinations of duodenogastric reflux, prevalence of Helicobacter pyroli infection, and concentrations of interleukin-8. World J Surg. 2003;27:567–70.PubMedCrossRef Fukuhara K, Osugi H, Takeda N, et al. Quantitative determinations of duodenogastric reflux, prevalence of Helicobacter pyroli infection, and concentrations of interleukin-8. World J Surg. 2003;27:567–70.PubMedCrossRef
Metadaten
Titel
Comparison of Billroth I and Roux-en-Y Reconstruction after Distal Gastrectomy for Gastric Cancer: One-year Postoperative Effects Assessed by a Multi-institutional RCT
verfasst von
Motohiro Hirao, MD, PhD
Shuji Takiguchi, MD, PhD
Hiroshi Imamura, MD, PhD
Kazuyoshi Yamamoto, MD, PhD
Yukinori Kurokawa, MD, PhD
Junya Fujita, MD, PhD
Kenji Kobayashi, MD, PhD
Yutaka Kimura, MD, PhD
Masaki Mori, MD, PhD
Yuichiro Doki, MD, PhD
Osaka University Clinical Research Group for Gastroenterological Study
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2704-9

Weitere Artikel der Ausgabe 5/2013

Annals of Surgical Oncology 5/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.